# Substudy of Protocol 2019-002498-80 - NCT04223050: Comparing Mortality for Low vs High Peripheral Oxygen Saturation in COPD-patients With Acute Exacerbation (O2flow-COPD)

> **NCT05052125** · PHASE4 · TERMINATED · sponsor: **Mikkel Brabrand** · enrollment: 23 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Oxygen

## Key facts

- **NCT ID:** NCT05052125
- **Lead sponsor:** Mikkel Brabrand
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-12-16
- **Primary completion:** 2024-08-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Lack of inclusion of patients
- **Last updated:** 2025-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05052125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05052125, "Substudy of Protocol 2019-002498-80 - NCT04223050: Comparing Mortality for Low vs High Peripheral Oxygen Saturation in COPD-patients With Acute Exacerbation (O2flow-COPD)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05052125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*